APP下载

BiPAP通气在老年慢性阻塞性肺疾病合并冠心病患者治疗中的应用效果体会

2016-05-24何鼎洋赵新生邓晓梅

中国实用医药 2016年15期
关键词:慢性阻塞性肺疾病临床疗效冠心病

何鼎洋+赵新生+邓晓梅

【摘要】 目的 探讨老年慢性阻塞性肺疾病合并冠心病患者采用双水平气道正压(BiPAP)通气的临床疗效。方法 108例老年慢性阻塞性肺疾病合并冠心病患者, 将其随机分为观察组与对照组, 各54例。

两组均予以抗感染、祛痰等常规治疗措施, 观察组患者在此基础上予以BiPAP通气治疗。观察两组治疗后的血气指标以及肺功能的恢复情况。结果 两组治疗后pH、动脉血氧分压(PaO2)、动脉血氧饱和度(SaO2)较治疗前明显上升(P<0.05), 且观察组上升趋势优于对照组(P<0.05);观察组患者治疗后一秒钟用力呼气容积占预计值百分比(FEV1%)、用力肺活量占预计值百分比(FVC%)均显著高于对照组(P<0.05)。

结论 BiPAP通气对老年慢性阻塞性肺疾病合并冠心病患者具有更好的临床疗效, 改善了患者的血氧指标, 促进肺功能的恢复, 可临床推广。

【关键词】 慢性阻塞性肺疾病;冠心病;双水平气道正压通气;临床疗效

DOI:10.14163/j.cnki.11-5547/r.2016.15.018

【Abstract】 Objective To investigate clinical effect by bi-level positive airway pressure (BiPAP) in the treatment of senile chronic obstructive pulmonary disease complicated with coronary heart disease patients. Methods A total of 108 senile chronic obstructive pulmonary disease complicated with coronary heart disease patients were randomly divided into observation group and control group, with 54 cases in each group. Both groups received anti-infection, and eliminating phlegm therapy, and the observation group received additional BiPAP. Blood gas indexes and pulmonary function recovery after treatment were observed in both groups. Results Both group had increased pH, arterial partial pressure of oxygen (PaO2) and arterial oxygen saturation (SaO2) after treatment (P<0.05), and those in the observation group were better than the control group (P<0.05). The observation group had much higher forced expiratory volume in 1 second percentage of predicted value (FEV1%) and forced vital capacity percentage of predicted value (FVC%) than the control group (P<0.05). Conclusion BiPAP provdes precise effect for senile chronic obstructive pulmonary disease complicated with coronary heart disease patients. This method improves blood oxygen index and accelerate pulmonary function, and it is worth clinical promotion.

【Key words】 Chronic obstructive pulmonary disease; Coronary heart disease; Bi-level positive airway pressure; Clinical effect

慢性阻塞性肺疾病(chronic obstructive pulmonary disease, COPD)简称慢阻肺, 是以不完全可逆的气流受限为特征的疾病, 且病情呈现出进行性发展, 通常合并呼吸衰竭等并发症, 具有极高的死亡率[1]。该病还可引发动脉粥样硬化或血管炎性, 在老年患者中具有较高的发生率, 在合并伴有冠心病的情况下则会进一步促进病情的恶化, 对患者的生命健康造成了极大的威胁。BiPAP通气作为一种新型的机械通气治疗措施, 具有操作简单、疗效确切的优势, 可缓解患者的病痛, 目前已在临床广泛使用。本次实验选取108例老年慢性阻塞性肺疾病合并冠心病患者作为研究对象, 探讨BiPAP通气的临床疗效, 具体报告如下。……

登录APP查看全文

猜你喜欢

慢性阻塞性肺疾病临床疗效冠心病
ADAMTs-1、 CF6、 CARP在冠心病合并慢性心力衰竭中的意义
茶、汁、饮治疗冠心病
警惕冠心病
无创正压通气联合参麦注射液治疗COPD并呼吸衰竭的临床效果
多元性护理干预对慢性阻塞性肺疾病长期家庭氧疗依从性的应用价值
无创机械通气联合盐酸氨溴索雾化治疗慢性阻塞性肺疾病伴Ⅱ型呼吸衰竭的效果分析
授权理论在使用无创呼吸机COPD患者健康教育中的应用
枸橼酸咖啡因治疗早产儿原发性呼吸暂停临床分析
微创手术治疗胃溃疡42例临床分析
研究腹腔镜在早期卵巢癌分期手术中的临床应用